Sign in and upgrade to a paid plan to export corporate actions as CSV.
Sign in and upgrade to a paid plan to export corporate actions as CSV.

ORTIN LABORATORIES LTD

BSE: 590074
₹7.73
▲ 1.05 (15.72%)
May 21, 2015 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
13/100
Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-18.6
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
15.7%
Low 7.1000 · High 7.7800
1W return
-12.1%
Low 6.6000 · High 8.8500
1M return
-20.4%
Low 6.6000 · High 10.2000
52W return
-34.9%
Low 6.6000 · High 19.0000
Lifetime High ₹38.8000 (Sept. 30, 2010)
Lifetime Low ₹6.6800 (May 20, 2015)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
7.9
10D
8.3
20D
8.7
50D
9.3
100D
10.1
200D
11.9

Delivery and volume

Day avg. delivery
86.0%
Week avg. delivery
85.7%
Month avg. delivery
82.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

7.54
Pivot
First resistance7.97
Second resistance8.22
Third resistance8.65
First support7.29
Second support6.86
Third support6.61
Day RSI37.8
Day MFI19.4
Day MACD-0.41
Day MACD signal-0.24

Beta

1M-0.09
3M1.08
1Y1.61
3Y0.65

Price change analysis

↓ -20.4%
Over 1 Month
LowHigh
6.6010.20
↓ -27.2%
Over 3 Months
LowHigh
6.6011.01
↓ -45.6%
Over 6 Months
LowHigh
6.6014.85
↓ -34.9%
Over 1 Year
LowHigh
6.6019.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Data unavailable.

Shareholding pattern / Ownership

Data unavailable.

Full shareholding pattern →

DateClientDealActionQuantityPriceExchange
28 Oct 2013 NIRMALABEN SURESHBHAI PARIKH Bulk Buy 25,000 14.2200 BSE
28 Oct 2013 B M TRADERS Bulk Sell 27,000 14.2100 BSE
14 Aug 2013 PRAVESH JAIN Bulk Sell 25,537 11.9600 BSE
31 May 2013 HARSHAD RASIKLAL SHETH Bulk Sell 47,200 14.9900 BSE
20 May 2013 B M TRADERS Bulk Sell 24,110 17.4900 BSE
25 Mar 2013 KIRIT RAMANLAL SHAH Bulk Sell 25,999 15.2900 BSE
25 Mar 2013 VIVEK AGARWAL Bulk Buy 50,000 15.2500 BSE
18 Mar 2013 YOGESHKUMAR R SANGHAVI Bulk Sell 30,725 20.3900 BSE
18 Mar 2013 B M TRADERS Bulk Buy 40,725 20.0200 BSE
15 Mar 2013 NISHA SUMANJAIN Bulk Buy 25,000 20.0500 BSE

All bulk and block deals →

Corporate Actions

Full history (6 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
21 Dec 2020OTHER Annual General Meeting
19 Sep 2019OTHER Annual General Meeting
19 Sep 2018OTHER Annual General Meeting
21 Sep 2017OTHER Annual General Meeting
22 Sep 2016OTHER Annual General Meeting

All corporate actions →

Corporate Announcements

All 126 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
13 Feb 2021 Financial Result Updates Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.
23 Jan 2021 Outcome of Board Meeting Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on January 23, 2021.
13 Jan 2021 Copy of Newspaper Publication Ortin Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
7 Jan 2021 Suspension of trading in equity shares Members of the Exchange are hereby informed that the trading in Equity Shares of Ortin Laboratories Limited shall be suspended w.e.f. January 12, 2021 on account of Scheme of Arrangement - Demerger and Capital Reduction
1 Jan 2021 Resignation Ortin Laboratories Limited has informed the Exchange regarding Resignation of Mrs T Uma Sangeetha as Non- Executive Independent Director of the company w.e.f. January 01, 2021.
1 Jan 2021 Record Date Ortin Laboratories Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 13-Jan-2021.
1 Jan 2021 Outcome of Board Meeting Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on January 01, 2021.
30 Dec 2020 Trading Window Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
30 Dec 2020 Updates Ortin Laboratories Limited has informed the Exchange regarding 'Update on Scheme of Arrangement between Ortin Laboratories Limited (Demerged Company) and Vineet Laboratories Limited (Resulting Company) (Receipt of NCLT order)'.
29 Dec 2020 Shareholders meeting Ortin Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on December 29, 2020. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 34.9% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about ORTIN LABORATORIES LTD

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.